Trends & Ideas: Stocking Up For The Diabetes Epidemic

SP Capital IQ |

S&P Capital IQ Equity Analyst Herman Saftlas joins Brian Egli, S&P Capital IQ Editorial, to discuss diabetes and where investment opportunities might lie with companies that are fighting this disease such as Johnson & Johnson (JNJ) . To read this and all Trends & Ideas content, please visit www.marketscope.com.

 



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
JNJ Johnson & Johnson 136.43 0.38 0.28 9,007,077 Trade
SGGHD Signature Group Hldgs New n/a n/a n/a 0

Comments

Emerging Growth

DynaCERT Inc.

DynaCERT Inc is engaged in the assembling, distributing and installation of a patent pending transportable hydrogen generator after-market product, for use in the heavy tractor-trailer industry and into large stationary…

Private Markets

Knightscope

Autonomous security robots providing advanced detection capabilities at $7 per hour - aiming to define the future of security. Help #StopTheViolence.

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…